| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mannose-Binding Lectin | 46 | 2016 | 140 | 6.630 |
Why?
|
| Complement Activation | 18 | 2016 | 463 | 1.860 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 9 | 2012 | 18 | 1.430 |
Why?
|
| Disseminated Intravascular Coagulation | 3 | 2014 | 193 | 1.290 |
Why?
|
| Lectins | 7 | 2016 | 557 | 1.190 |
Why?
|
| Complement Pathway, Mannose-Binding Lectin | 14 | 2014 | 26 | 1.150 |
Why?
|
| Mannose-Binding Lectins | 6 | 2013 | 108 | 1.150 |
Why?
|
| Complement Pathway, Alternative | 12 | 2014 | 130 | 1.130 |
Why?
|
| Teichoic Acids | 6 | 2016 | 71 | 0.980 |
Why?
|
| Thrombin | 5 | 2021 | 615 | 0.970 |
Why?
|
| Staphylococcal Infections | 9 | 2016 | 1371 | 0.930 |
Why?
|
| Complement Factor B | 3 | 2021 | 79 | 0.900 |
Why?
|
| Orthomyxoviridae Infections | 4 | 2013 | 232 | 0.900 |
Why?
|
| Complement C3 | 9 | 2012 | 462 | 0.900 |
Why?
|
| Influenza A virus | 5 | 2014 | 452 | 0.830 |
Why?
|
| Complement System Proteins | 9 | 2016 | 826 | 0.810 |
Why?
|
| Trypsin | 1 | 2021 | 540 | 0.790 |
Why?
|
| Staphylococcus aureus | 12 | 2016 | 1391 | 0.780 |
Why?
|
| Collectins | 4 | 2016 | 20 | 0.760 |
Why?
|
| Cell Wall | 5 | 2016 | 451 | 0.710 |
Why?
|
| Immunity, Innate | 12 | 2016 | 2937 | 0.620 |
Why?
|
| Arthritis, Experimental | 7 | 2013 | 287 | 0.600 |
Why?
|
| Mice, Knockout | 40 | 2021 | 15274 | 0.520 |
Why?
|
| Ventilator-Induced Lung Injury | 2 | 2013 | 118 | 0.510 |
Why?
|
| Antiviral Agents | 6 | 2013 | 2768 | 0.500 |
Why?
|
| Immunoglobulin G | 10 | 2016 | 4422 | 0.480 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2013 | 365 | 0.440 |
Why?
|
| Mice, Inbred C57BL | 36 | 2021 | 22989 | 0.440 |
Why?
|
| Receptors, Pattern Recognition | 2 | 2012 | 78 | 0.420 |
Why?
|
| Blood Coagulation | 3 | 2011 | 1114 | 0.420 |
Why?
|
| Phagocytosis | 9 | 2016 | 1594 | 0.420 |
Why?
|
| Disease Susceptibility | 6 | 2011 | 1778 | 0.410 |
Why?
|
| Mice | 66 | 2018 | 80876 | 0.410 |
Why?
|
| Inflammation | 15 | 2014 | 10019 | 0.400 |
Why?
|
| Reperfusion Injury | 8 | 2012 | 1071 | 0.380 |
Why?
|
| Animals | 80 | 2022 | 170486 | 0.370 |
Why?
|
| Influenza, Human | 4 | 2016 | 1344 | 0.340 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 652 | 0.310 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 4 | 2016 | 461 | 0.310 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 2006 | 67 | 0.310 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2010 | 3878 | 0.310 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 2006 | 69 | 0.300 |
Why?
|
| Immunologic Factors | 2 | 2013 | 1578 | 0.300 |
Why?
|
| Complement C1q | 8 | 2012 | 96 | 0.300 |
Why?
|
| Complement Pathway, Classical | 6 | 2014 | 102 | 0.300 |
Why?
|
| Horse Diseases | 1 | 2006 | 52 | 0.300 |
Why?
|
| Dermis | 1 | 2007 | 214 | 0.280 |
Why?
|
| Antibody Formation | 2 | 2010 | 1419 | 0.270 |
Why?
|
| Burns | 2 | 2007 | 1788 | 0.270 |
Why?
|
| Ebolavirus | 3 | 2013 | 244 | 0.270 |
Why?
|
| Opsonin Proteins | 5 | 2016 | 154 | 0.260 |
Why?
|
| Interleukin-6 | 5 | 2019 | 3179 | 0.260 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2018 | 323 | 0.250 |
Why?
|
| Epidermis | 1 | 2007 | 539 | 0.250 |
Why?
|
| Mannose | 3 | 2010 | 122 | 0.250 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2022 | 15 | 0.240 |
Why?
|
| Amyloid beta-Peptides | 2 | 2014 | 3167 | 0.240 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2022 | 37 | 0.240 |
Why?
|
| Radiopharmaceuticals | 4 | 2020 | 2708 | 0.240 |
Why?
|
| 4-Aminopyridine | 1 | 2022 | 85 | 0.230 |
Why?
|
| Radioactive Tracers | 1 | 2022 | 81 | 0.230 |
Why?
|
| Thiourea | 1 | 2022 | 67 | 0.230 |
Why?
|
| Disease Models, Animal | 14 | 2018 | 18375 | 0.210 |
Why?
|
| Pseudomonas Infections | 1 | 2006 | 620 | 0.210 |
Why?
|
| Communicable Diseases | 2 | 2008 | 797 | 0.210 |
Why?
|
| Calcium Channels, L-Type | 1 | 2022 | 238 | 0.210 |
Why?
|
| Immunoglobulin M | 5 | 2010 | 1527 | 0.210 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2006 | 1178 | 0.200 |
Why?
|
| Positron-Emission Tomography | 6 | 2022 | 6170 | 0.200 |
Why?
|
| Antibodies, Bacterial | 4 | 2016 | 1446 | 0.200 |
Why?
|
| Demyelinating Diseases | 1 | 2022 | 368 | 0.190 |
Why?
|
| Immunization | 4 | 2016 | 1273 | 0.190 |
Why?
|
| Peritonitis | 1 | 2002 | 380 | 0.190 |
Why?
|
| Glycoproteins | 4 | 2016 | 2309 | 0.190 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2011 | 851 | 0.190 |
Why?
|
| Complement C4 | 5 | 2012 | 272 | 0.180 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2008 | 17218 | 0.180 |
Why?
|
| Collagen Type II | 2 | 2009 | 135 | 0.170 |
Why?
|
| Myocardium | 4 | 2012 | 4969 | 0.170 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2020 | 1988 | 0.170 |
Why?
|
| Liver Diseases | 1 | 2006 | 1246 | 0.170 |
Why?
|
| Phylogeny | 2 | 2021 | 2799 | 0.170 |
Why?
|
| Phagosomes | 2 | 2010 | 212 | 0.160 |
Why?
|
| Antigen-Antibody Complex | 5 | 2012 | 534 | 0.160 |
Why?
|
| Molecular Imaging | 2 | 2022 | 853 | 0.160 |
Why?
|
| Matrix Metalloproteinases | 2 | 2011 | 409 | 0.150 |
Why?
|
| Toll-Like Receptors | 3 | 2009 | 594 | 0.150 |
Why?
|
| Phosphatidylcholines | 1 | 2018 | 438 | 0.150 |
Why?
|
| Neuralgia | 1 | 2022 | 514 | 0.150 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2021 | 2926 | 0.150 |
Why?
|
| Macrophages, Alveolar | 2 | 2014 | 441 | 0.150 |
Why?
|
| Complement C6 | 2 | 2012 | 22 | 0.140 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2018 | 241 | 0.140 |
Why?
|
| Polysaccharides | 3 | 2012 | 991 | 0.140 |
Why?
|
| Adipocytes | 2 | 2013 | 1181 | 0.140 |
Why?
|
| Respiratory Mechanics | 1 | 2019 | 642 | 0.140 |
Why?
|
| Liver | 3 | 2010 | 7622 | 0.130 |
Why?
|
| Cromolyn Sodium | 1 | 2014 | 94 | 0.130 |
Why?
|
| Mice, Mutant Strains | 3 | 2007 | 1956 | 0.130 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2016 | 352 | 0.130 |
Why?
|
| Models, Biological | 3 | 2012 | 9907 | 0.130 |
Why?
|
| Extracorporeal Circulation | 1 | 2014 | 188 | 0.130 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2009 | 496 | 0.130 |
Why?
|
| Filoviridae Infections | 1 | 2013 | 5 | 0.130 |
Why?
|
| Injections, Intradermal | 1 | 2013 | 129 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2021 | 14215 | 0.120 |
Why?
|
| Receptors, Mitogen | 1 | 2013 | 64 | 0.120 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2011 | 88 | 0.120 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2016 | 589 | 0.120 |
Why?
|
| Neutrophils | 4 | 2016 | 3867 | 0.120 |
Why?
|
| Receptors, Complement | 2 | 2011 | 258 | 0.120 |
Why?
|
| Respiratory Mucosa | 1 | 2016 | 465 | 0.120 |
Why?
|
| Binding Sites | 2 | 2021 | 6276 | 0.120 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2006 | 3418 | 0.110 |
Why?
|
| Onium Compounds | 1 | 2012 | 35 | 0.110 |
Why?
|
| Solubility | 3 | 2010 | 1156 | 0.110 |
Why?
|
| Influenza A Virus, H9N2 Subtype | 1 | 2011 | 8 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2014 | 3968 | 0.110 |
Why?
|
| Neutralization Tests | 2 | 2012 | 735 | 0.110 |
Why?
|
| Artificial Organs | 1 | 2014 | 203 | 0.110 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2012 | 82 | 0.110 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2011 | 56 | 0.110 |
Why?
|
| Ligands | 3 | 2022 | 3297 | 0.110 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2011 | 34 | 0.110 |
Why?
|
| Autoradiography | 1 | 2013 | 795 | 0.110 |
Why?
|
| Cell Division | 1 | 2020 | 4752 | 0.110 |
Why?
|
| Cryptococcus | 1 | 2011 | 31 | 0.110 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2011 | 96 | 0.110 |
Why?
|
| Blood Coagulation Disorders | 1 | 2014 | 341 | 0.110 |
Why?
|
| Endotoxemia | 1 | 2013 | 219 | 0.110 |
Why?
|
| Antigens, Fungal | 1 | 2011 | 81 | 0.110 |
Why?
|
| Hemagglutination, Viral | 1 | 2010 | 12 | 0.110 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2010 | 250 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2020 | 3014 | 0.110 |
Why?
|
| Spleen | 3 | 2014 | 2473 | 0.110 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2013 | 291 | 0.100 |
Why?
|
| Recombinant Proteins | 6 | 2014 | 6850 | 0.100 |
Why?
|
| Chagas Disease | 1 | 2012 | 162 | 0.100 |
Why?
|
| Organophosphorus Compounds | 1 | 2012 | 222 | 0.100 |
Why?
|
| Antibodies, Fungal | 1 | 2010 | 31 | 0.100 |
Why?
|
| Peptide Fragments | 4 | 2014 | 5141 | 0.100 |
Why?
|
| Trypanosoma cruzi | 1 | 2012 | 195 | 0.100 |
Why?
|
| Epitopes | 2 | 2016 | 2646 | 0.100 |
Why?
|
| Host-Parasite Interactions | 1 | 2012 | 291 | 0.100 |
Why?
|
| Neuraminidase | 1 | 2010 | 204 | 0.100 |
Why?
|
| Central Nervous System Depressants | 1 | 2011 | 168 | 0.100 |
Why?
|
| Leukocytes | 2 | 2013 | 2095 | 0.100 |
Why?
|
| Viral Load | 4 | 2016 | 3231 | 0.100 |
Why?
|
| Mitochondria, Heart | 1 | 2012 | 262 | 0.100 |
Why?
|
| Complement C3a | 2 | 2011 | 70 | 0.100 |
Why?
|
| Tuberous Sclerosis | 1 | 2018 | 1007 | 0.100 |
Why?
|
| Nod Signaling Adaptor Proteins | 1 | 2009 | 3 | 0.100 |
Why?
|
| Complement Inactivator Proteins | 1 | 2009 | 84 | 0.100 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 1948 | 0.100 |
Why?
|
| Complement Factor D | 4 | 2011 | 66 | 0.100 |
Why?
|
| Phagocytes | 1 | 2011 | 306 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2016 | 4466 | 0.090 |
Why?
|
| Brain | 4 | 2022 | 24969 | 0.090 |
Why?
|
| Receptors, Complement 3d | 1 | 2009 | 133 | 0.090 |
Why?
|
| Complement Factor H | 1 | 2009 | 111 | 0.090 |
Why?
|
| Protein Binding | 6 | 2016 | 9639 | 0.090 |
Why?
|
| Humans | 45 | 2021 | 708843 | 0.090 |
Why?
|
| Virus Internalization | 1 | 2013 | 463 | 0.090 |
Why?
|
| Coxiella burnetii | 1 | 2009 | 33 | 0.090 |
Why?
|
| Respiratory Tract Diseases | 1 | 2014 | 684 | 0.090 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2159 | 0.090 |
Why?
|
| Hepatitis B Antibodies | 1 | 2009 | 149 | 0.090 |
Why?
|
| Hemangioma | 1 | 1994 | 741 | 0.090 |
Why?
|
| Cytokines | 6 | 2019 | 7189 | 0.090 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2008 | 343 | 0.090 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2008 | 25 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2012 | 11239 | 0.090 |
Why?
|
| Immunohistochemistry | 9 | 2018 | 11790 | 0.080 |
Why?
|
| Virus Replication | 2 | 2016 | 2524 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 2421 | 0.080 |
Why?
|
| Macrophages | 3 | 2012 | 5784 | 0.080 |
Why?
|
| Epidermolysis Bullosa Acquisita | 1 | 2007 | 16 | 0.080 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2007 | 56 | 0.080 |
Why?
|
| Complement C4b | 1 | 2007 | 135 | 0.080 |
Why?
|
| Choroidal Neovascularization | 1 | 2011 | 353 | 0.080 |
Why?
|
| Pneumonia | 1 | 2019 | 2080 | 0.080 |
Why?
|
| Adoptive Transfer | 1 | 2010 | 874 | 0.080 |
Why?
|
| Sepsis | 2 | 2014 | 2449 | 0.080 |
Why?
|
| Pneumococcal Infections | 1 | 2012 | 556 | 0.080 |
Why?
|
| Blister | 1 | 2007 | 91 | 0.080 |
Why?
|
| Dimerization | 1 | 2008 | 909 | 0.080 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1670 | 0.080 |
Why?
|
| Rats | 5 | 2022 | 25094 | 0.080 |
Why?
|
| Drug Approval | 1 | 2014 | 868 | 0.080 |
Why?
|
| Seasons | 1 | 2012 | 1433 | 0.080 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2012 | 618 | 0.070 |
Why?
|
| Streptococcus pneumoniae | 1 | 2012 | 780 | 0.070 |
Why?
|
| Lasers | 1 | 2011 | 945 | 0.070 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2007 | 243 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2021 | 6666 | 0.070 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2010 | 552 | 0.070 |
Why?
|
| Models, Immunological | 1 | 2008 | 529 | 0.070 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2011 | 390 | 0.070 |
Why?
|
| Metabolic Clearance Rate | 1 | 2006 | 401 | 0.070 |
Why?
|
| Brain Injuries | 2 | 2008 | 1909 | 0.070 |
Why?
|
| Horses | 1 | 2006 | 292 | 0.070 |
Why?
|
| Receptors, Fc | 1 | 2009 | 562 | 0.070 |
Why?
|
| Dermatitis | 1 | 2007 | 194 | 0.070 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2005 | 237 | 0.070 |
Why?
|
| Apoptosis | 3 | 2014 | 10085 | 0.070 |
Why?
|
| Ethanol | 1 | 2011 | 1245 | 0.070 |
Why?
|
| Cell Line | 5 | 2013 | 16657 | 0.070 |
Why?
|
| Models, Animal | 2 | 2008 | 2221 | 0.070 |
Why?
|
| Mitochondria | 1 | 2018 | 3665 | 0.070 |
Why?
|
| Permeability | 2 | 2022 | 791 | 0.060 |
Why?
|
| Isoantibodies | 1 | 2007 | 660 | 0.060 |
Why?
|
| Herpesvirus 2, Human | 1 | 2004 | 176 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10803 | 0.060 |
Why?
|
| Cation Transport Proteins | 1 | 2006 | 330 | 0.060 |
Why?
|
| Risk Factors | 4 | 2014 | 69553 | 0.060 |
Why?
|
| Blotting, Western | 4 | 2013 | 5456 | 0.060 |
Why?
|
| Airway Resistance | 1 | 2004 | 393 | 0.060 |
Why?
|
| Colitis | 1 | 2010 | 1140 | 0.060 |
Why?
|
| Fibroblasts | 1 | 2013 | 4299 | 0.060 |
Why?
|
| Kinetics | 2 | 2010 | 6796 | 0.060 |
Why?
|
| Bacteremia | 2 | 2005 | 968 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2008 | 4353 | 0.050 |
Why?
|
| Male | 22 | 2018 | 349524 | 0.050 |
Why?
|
| Herpes Simplex | 1 | 2004 | 466 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2005 | 1897 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2006 | 2281 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2006 | 612 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 2 | 2016 | 58 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2013 | 3690 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 9584 | 0.050 |
Why?
|
| Pneumocystis | 1 | 2000 | 56 | 0.050 |
Why?
|
| Calcium | 2 | 2012 | 5825 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 4941 | 0.050 |
Why?
|
| Mycoses | 1 | 2004 | 368 | 0.050 |
Why?
|
| Haplotypes | 1 | 2007 | 2874 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2006 | 2064 | 0.050 |
Why?
|
| Age Factors | 2 | 2016 | 18712 | 0.050 |
Why?
|
| Cells, Cultured | 6 | 2016 | 20170 | 0.050 |
Why?
|
| Primates | 1 | 2022 | 503 | 0.050 |
Why?
|
| Pluripotent Stem Cells | 1 | 2007 | 803 | 0.050 |
Why?
|
| Pulmonary Surfactants | 1 | 2000 | 174 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 18748 | 0.050 |
Why?
|
| Kidney | 3 | 2010 | 6888 | 0.050 |
Why?
|
| Adaptive Immunity | 2 | 2016 | 704 | 0.050 |
Why?
|
| Endothelial Cells | 1 | 2013 | 3417 | 0.050 |
Why?
|
| Movement | 1 | 2007 | 1459 | 0.050 |
Why?
|
| Lung | 5 | 2011 | 9706 | 0.050 |
Why?
|
| Retina | 1 | 2011 | 2649 | 0.050 |
Why?
|
| Adipose Tissue | 1 | 2011 | 3234 | 0.050 |
Why?
|
| Fluoroacetates | 1 | 2018 | 17 | 0.050 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2000 | 243 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1386 | 0.050 |
Why?
|
| Anaphylaxis | 1 | 2006 | 748 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2010 | 3070 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2005 | 834 | 0.040 |
Why?
|
| Homeostasis | 2 | 2007 | 3334 | 0.040 |
Why?
|
| Receptors, IgG | 1 | 2002 | 612 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2012 | 3260 | 0.040 |
Why?
|
| Female | 15 | 2018 | 375205 | 0.040 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2006 | 1269 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2009 | 2726 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 2 | 2010 | 277 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2007 | 2376 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 2005 | 1156 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2000 | 617 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2005 | 1423 | 0.040 |
Why?
|
| Choline | 1 | 2018 | 471 | 0.040 |
Why?
|
| Autoimmunity | 1 | 2005 | 1325 | 0.040 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 9927 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2007 | 3053 | 0.040 |
Why?
|
| RNA Interference | 1 | 2006 | 3026 | 0.040 |
Why?
|
| Serum Amyloid P-Component | 1 | 2016 | 47 | 0.040 |
Why?
|
| Blood-Brain Barrier | 1 | 2022 | 992 | 0.040 |
Why?
|
| Complement C2 | 2 | 2005 | 86 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 2 | 2016 | 1482 | 0.040 |
Why?
|
| Phenotype | 3 | 2010 | 16306 | 0.030 |
Why?
|
| Flavonols | 1 | 2014 | 76 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 4861 | 0.030 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 2913 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 7165 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 1994 | 102 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 1673 | 0.030 |
Why?
|
| Aged | 6 | 2018 | 161488 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2007 | 3079 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2011 | 10507 | 0.030 |
Why?
|
| Base Sequence | 1 | 2006 | 13352 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2002 | 2838 | 0.030 |
Why?
|
| Collagenases | 1 | 1994 | 236 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2005 | 2117 | 0.030 |
Why?
|
| U937 Cells | 1 | 2014 | 281 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1994 | 289 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2020 | 3258 | 0.030 |
Why?
|
| Complement Fixation Tests | 1 | 2012 | 78 | 0.030 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2012 | 59 | 0.030 |
Why?
|
| Biomedical Engineering | 1 | 2014 | 298 | 0.030 |
Why?
|
| Pinocytosis | 1 | 2013 | 82 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2009 | 11718 | 0.030 |
Why?
|
| Biomimetic Materials | 1 | 2014 | 181 | 0.030 |
Why?
|
| Brain Edema | 2 | 2008 | 616 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2016 | 551 | 0.030 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2012 | 117 | 0.030 |
Why?
|
| Heart | 1 | 2006 | 4315 | 0.030 |
Why?
|
| Mast Cells | 2 | 2006 | 1601 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2005 | 1896 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2013 | 3609 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 756 | 0.030 |
Why?
|
| Pandemics | 1 | 2012 | 7089 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1994 | 775 | 0.030 |
Why?
|
| Coronary Artery Disease | 1 | 2012 | 6213 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2006 | 6048 | 0.030 |
Why?
|
| Dogs | 2 | 2012 | 4059 | 0.030 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2013 | 181 | 0.030 |
Why?
|
| Alanine Transaminase | 2 | 2005 | 600 | 0.030 |
Why?
|
| Vero Cells | 1 | 2013 | 472 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 2046 | 0.030 |
Why?
|
| Flavonoids | 1 | 2014 | 421 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1994 | 629 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2014 | 39292 | 0.030 |
Why?
|
| Endotoxins | 1 | 2014 | 558 | 0.030 |
Why?
|
| Endothelial Growth Factors | 1 | 1994 | 696 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 1928 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2006 | 3354 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2016 | 1001 | 0.030 |
Why?
|
| Magnetics | 1 | 2014 | 645 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 3490 | 0.030 |
Why?
|
| Lymphokines | 1 | 1994 | 966 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 4969 | 0.030 |
Why?
|
| Viral Matrix Proteins | 1 | 2012 | 285 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2022 | 8593 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 1994 | 696 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14836 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2012 | 455 | 0.020 |
Why?
|
| Stroke | 1 | 2012 | 9256 | 0.020 |
Why?
|
| Synovial Membrane | 1 | 2013 | 497 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2014 | 2015 | 0.020 |
Why?
|
| Middle Aged | 5 | 2014 | 213752 | 0.020 |
Why?
|
| Rabbits | 2 | 2007 | 5163 | 0.020 |
Why?
|
| Escherichia coli | 2 | 2014 | 4316 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2011 | 365 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 252 | 0.020 |
Why?
|
| Calreticulin | 1 | 2010 | 106 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2011 | 420 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2013 | 61932 | 0.020 |
Why?
|
| Viral Envelope Proteins | 1 | 2013 | 589 | 0.020 |
Why?
|
| Immune System | 2 | 2008 | 806 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 666 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 9774 | 0.020 |
Why?
|
| Q Fever | 1 | 2009 | 31 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2010 | 291 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1999 | 0.020 |
Why?
|
| Acute Lung Injury | 1 | 2013 | 377 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2011 | 220 | 0.020 |
Why?
|
| Electroretinography | 1 | 2011 | 547 | 0.020 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2011 | 286 | 0.020 |
Why?
|
| Chlorides | 1 | 2011 | 710 | 0.020 |
Why?
|
| Oximetry | 1 | 2012 | 470 | 0.020 |
Why?
|
| Stem Cells | 1 | 2002 | 3593 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6293 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2011 | 6127 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 857 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2013 | 3812 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2014 | 758 | 0.020 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2009 | 288 | 0.020 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2009 | 315 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 1468 | 0.020 |
Why?
|
| Collagen Type VII | 1 | 2007 | 15 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 19423 | 0.020 |
Why?
|
| Swine | 1 | 2018 | 5763 | 0.020 |
Why?
|
| Zymosan | 1 | 2007 | 131 | 0.020 |
Why?
|
| Microscopy | 1 | 2013 | 873 | 0.020 |
Why?
|
| Candidiasis | 1 | 2010 | 367 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 2007 | 174 | 0.020 |
Why?
|
| Carbohydrates | 1 | 2009 | 359 | 0.020 |
Why?
|
| CHO Cells | 1 | 2010 | 1438 | 0.020 |
Why?
|
| Immune Sera | 1 | 2007 | 702 | 0.020 |
Why?
|
| Candida albicans | 1 | 2010 | 372 | 0.020 |
Why?
|
| Chemokines | 1 | 2011 | 954 | 0.020 |
Why?
|
| Myosin Type II | 1 | 2006 | 66 | 0.020 |
Why?
|
| Immunity, Mucosal | 1 | 2010 | 485 | 0.020 |
Why?
|
| Adult | 7 | 2013 | 211041 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2009 | 407 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2010 | 596 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2009 | 633 | 0.020 |
Why?
|
| Infant | 3 | 2013 | 34261 | 0.020 |
Why?
|
| Microglia | 1 | 2014 | 1160 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2000 | 5141 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2007 | 11323 | 0.020 |
Why?
|
| Cricetinae | 1 | 2010 | 2588 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2009 | 23950 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 412 | 0.020 |
Why?
|
| Mesentery | 1 | 2006 | 209 | 0.020 |
Why?
|
| Mutation | 2 | 2013 | 29262 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 2138 | 0.020 |
Why?
|
| Equipment Design | 1 | 2014 | 3627 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 15485 | 0.020 |
Why?
|
| Fibrosis | 1 | 2012 | 1947 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2007 | 291 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2012 | 1652 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1740 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2005 | 3972 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 1835 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2006 | 674 | 0.020 |
Why?
|
| Receptors, Scavenger | 1 | 2005 | 128 | 0.020 |
Why?
|
| Asthma | 1 | 2004 | 5850 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 2635 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2007 | 6684 | 0.020 |
Why?
|
| Hypothermia | 1 | 2006 | 178 | 0.020 |
Why?
|
| Maze Learning | 1 | 2007 | 499 | 0.020 |
Why?
|
| Troponin I | 1 | 2009 | 632 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2007 | 15053 | 0.020 |
Why?
|
| Myosin Heavy Chains | 1 | 2006 | 407 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2010 | 58184 | 0.020 |
Why?
|
| Ovalbumin | 1 | 2006 | 729 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 1922 | 0.020 |
Why?
|
| Drug Design | 1 | 2010 | 1100 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 16959 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2009 | 1925 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2005 | 276 | 0.020 |
Why?
|
| Encephalitis | 1 | 2008 | 446 | 0.020 |
Why?
|
| Herpes Genitalis | 1 | 2004 | 131 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2013 | 24433 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 941 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 2005 | 343 | 0.020 |
Why?
|
| Cattle | 1 | 2009 | 4006 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6530 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4310 | 0.020 |
Why?
|
| Dextrans | 1 | 2005 | 619 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2011 | 13314 | 0.010 |
Why?
|
| Aspergillus fumigatus | 1 | 2004 | 149 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2006 | 831 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 2009 | 1192 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 2005 | 519 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2006 | 860 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2005 | 597 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2836 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 8024 | 0.010 |
Why?
|
| Germinal Center | 1 | 2005 | 363 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2007 | 713 | 0.010 |
Why?
|
| Cell Death | 1 | 2008 | 1738 | 0.010 |
Why?
|
| Autoantigens | 1 | 2006 | 914 | 0.010 |
Why?
|
| Peroxidase | 1 | 2005 | 636 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2012 | 4211 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2006 | 1918 | 0.010 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2000 | 79 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2005 | 981 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2012 | 1819 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 8968 | 0.010 |
Why?
|
| Necrosis | 1 | 2005 | 1646 | 0.010 |
Why?
|
| Monosaccharides | 1 | 2000 | 66 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2005 | 1634 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 1849 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2007 | 1378 | 0.010 |
Why?
|
| Weight Loss | 1 | 2011 | 2450 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 3995 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1994 | 11126 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2007 | 4831 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2004 | 1528 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2005 | 1482 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 20308 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 2244 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2008 | 1959 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2010 | 2930 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 5982 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2010 | 1825 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2007 | 1976 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2004 | 1132 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 1938 | 0.010 |
Why?
|